FDA inspection
Johnson & Johnson Pharmaceutical Research & Development, LLC: FDA inspection ending Jun 12, 2008
FDA inspection 523128 · Official Action Indicated (OAI) · Raritan, NJ
Key facts
| Inspection ID | 523128 |
|---|---|
| Firm | Johnson & Johnson Pharmaceutical Research & Development, LLC |
| FEI number | 3006192174 |
| Address | 920 U.S. Highway 202, P.O. Box 300 |
| City | Raritan |
| State | NJ |
| ZIP | 08869-0602 |
| Fiscal year | 2008 |
| Inspection end date | Jun 12, 2008 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data